Chicago Hope?

Writers from Seattle Treatment Education Project (STEP) and The Center For AIDS in Houston, TX, in collaboration with The Body, are proud to be posting daily highlights from the 5th Conference on Retroviruses and Opportunistic Infections.

Due to time constraints, highlights from select presentations will be posted. The organizers of the conference have posted all the abstracts and some audio/video presentations on the following Web site:
http://www.retroconference.org.

Look for more complete coverage from STEP and The Center for AIDS online at, http://www.thebody.com/step/steppage.html and
http://www.centerforaids.org.

Index of Conference Reports:

Summary by Jeffrey Schouten, M.D., Chairman, Scientific Review Committee
Seattle Treatment Education Project

Monday, February 2, 1998

• State-of-the-Art Lecture Presenter -- Kevin Decock, CDC
  Summary by Jeffrey Schouten, M.D.
  Seattle Treatment Education Project
• Immunopathogenesis Symposium
  Summary by Jeffrey Schouten, M.D.
  Seattle Treatment Education Project
• Chemokine Receptor Symposium
  Summary by Jeffrey Schouten, M.D.
  Seattle Treatment Education Project
• Antiretroviral Chemotherapy I
  Summary by Brian Coppedge, Treatment Information Specialist
  Seattle Treatment Education Project
• Studies of HIV Infection in Women (I)
  Summaries by Donna Rochon, Editor, RITA!
  The Center for AIDS, Houston, TX
  1. Session 8: AIDS Malignancies
  2. Session 29, Poster 207: Quantitative HIV-1 RNA and Other Factors Associated with Survival in the Women's Interagency HIV Study (WIHS)
• Three Poster Presentations
  Summaries by Paul Simmons, RN
  The Center for AIDS, Houston, TX
  1. Session 29, Poster 217 by Andrew Kanter et al, WITS Medical School, Johannesburg, South Africa
  2. Session 24, Poster 148 by Pamela Bozek et al, University of Maryland, Baltimore
  3. Session 29, Poster 208 by LP Jacobson et al, Johns Hopkins School of Public Health, Baltimore

Tuesday, February 3, 1998

• State-of-the-Art-Lecture: HIV Infection: The Body Fights Back
  Summary by Jeffrey Schouten, M.D.
  Seattle Treatment Education Project
• Neurologic Aspects of HIV Disease
  Summaries by Donna Rochon, Editor, RITA!
  The Center for AIDS, Houston, TX
  1. S20: The Molecular Pathogenesis of Progressive Multifocal Leukoencephalopathy
  2. S22: HIV-1 Viral Load in the CSF and Brain
• An Early Look at b.i.d. Dosing Regimens for Nelfinavir
  Summary by Donna Rochon, Editor, RITA!
  The Center for AIDS, Houston, TX
• Studies of HIV Infection in Women (II)
  Summary by Donna Rochon, Editor, RITA!
  The Center for AIDS, Houston, TX
  1. Session 49, Poster 356: Indinavir Pharmacokinetics and Menstrual Cycle Physiology
• Four Poster Sessions
  Summaries by Paul Simmons, RN
  The Center for AIDS, Houston, TX
  1. Session 47, Poster 326: Ultra Sensitive Detection of Plasma HIV-1 RNA for Predicting the Durability of 3-Drug Antiretroviral Therapy
  2. Session 50, Poster 387: Can Nelfinavir Substitute for Other Protease Inhibitors in Persons with Plasma HIV-1 RNA Below 500 copies/ml Before the Substitution?
  3. Session 50, Poster 374: Thirty-Two Week Follow-Up of Indinavir Sulfate Administered Q8 Hours versus Q12 in Combination with Zidovudine and Lamivudine
  4. Session 54, Poster 426: Salvage Therapy Using Six Drugs in Heavily Pretreated Patients

Wednesday, February 4, 1998

• Studies of HIV Infection in Women (III)
  Summary by Donna Rochon, Editor, RITA!
  The Center for AIDS, Houston, TX
  1. Session 88: HIV Replication in the Female Genital Tract
  2. Session 89, Poster 722: Women First: A Study in HIV Positive Women of Quadruple Therapy: Nelfinavir, Saquinavir, Stavudine, and Lamivudine